Toru Yoden

Novel potassium channel openers. Part 4: transformation of the 1,4-benzoxazine skeleton into 1,4-benzothiazine, 1,2,3,4-tetrahydroquinoline, 1,2,3,4-tetrahydroquinoxaline, indoline, and 1,5-benzoxazepine

Yuzo Matsumoto, Ryuji Tsuzuki, Akira Matsuhisa et al. · Bioorganic & Medicinal Chemistry · 2000 · 47 citations

Biochemistry, Medicine, Organic Chemistry +6

Novel Potassium Channel Activators: Synthesis and Structure-Activity Relationship Studies of 3,4-Dihydro-2H-1,4-benzoxazine Derivatives.

Yuzo Matsumoto, Ryuji Tsuzuki, Toru Yoden et al. · Chemical and Pharmaceutical Bulletin · 1996 · 45 citations · Full text

Studies on Aromatase Inhibitors. I. Synthesis and Biological Evaluation of 4-Amino-4H-1,2,4-triazole Derivatives.

Minoru Okada, Toru Yoden, Eiji Kawaminami et al. · Chemical and Pharmaceutical Bulletin · 1996 · 38 citations · Full text

Hormonal Contraceptive, Gynecology, Pharmacotherapy +19

Novel nonsteroidal inhibitor of cytochrome P45017α (17α-hydroxylase/C17–20 lyase), YM116, decreased prostatic weights by reducing serum concentrations of testosterone and adrenal androgens in rats

Yukitaka Ideyama, Masafumi Kudoh, Kyoko Tanimoto et al. · The Prostate · 1998 · 35 citations

Spermatogenesis, Novel Nonsteroidal Inhibitor, Prostatic Weight +21

Synthesis and Pharmacological Evaluation of Novel Arylpiperazine Derivatives as Nonsteroidal Androgen Receptor Antagonists

Isao Kinoyama, Nobuaki Taniguchi, Toru Yoden et al. · Chemical and Pharmaceutical Bulletin · 2004 · 16 citations · Full text

Pharmacotherapy, Heterocycle Chemistry, Lead Compound +16